Cytotoxic and anti-tumor effects of 3,4-seco-lupane triterpenoids from the leaves of Eleutherococcus sessiliflorus against hepatocellular carcinoma

被引:7
|
作者
Wang, Haohao [1 ]
Yu, Wenliu [2 ]
Zhang, Danfeng [1 ]
Zhao, Yan [1 ]
Chen, Chen [1 ]
Zhu, Hongyan [1 ]
Cai, Enbo [1 ]
Yan, Zhaowei [2 ]
机构
[1] Jilin Agr Univ, Coll Chinese Med Mat, Changchun, Peoples R China
[2] Soochow Univ, Affiliated Hosp 1, Dept Pharm, Suzhou, Peoples R China
关键词
Eleutherococcus sessiliflorus; 3; 4-seco-lupane triterpenoids; anti-tumor; molecule docking;
D O I
10.1080/14786419.2020.1844698
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
A rich of 3,4-seco-lupane triterpenoids (3,4-SLT), including chiisanoside (CSS), divaroside (DVS), sessiloside-A1 (SSA), chiisanogenin (CSG), sessiligenin (SSG), were isolated from the ethanol extract of the leaves of Eleutherococcus sessiliflorus (LES). The present study was performed to explore the cytotoxic and anti-tumor effects of the isolated five ones, as well as potential molecular mechanisms. The results of a CCK-8 assay demonstrated that these 3,4-SLT can inhibit the growth of HepG2 cells, and SSG showed the most significant cytotoxicity. Hoechst 33258 fluorescence staining and Annexin V-FITC/PI staining indicated that 3,4-SLT in LES can induce HepG2 cell apoptosis effectively. The AutoDock Vina program was used to simulate molecular docking of drugs and targets to discuss possible pharmacological mechanisms. Besides, western blot and qRT-PCR results indicated that SSG can inhibit PI3K/AKT signaling pathway through controlling multi-targets. This study suggested that 3,4-SLT might become a new research hotspot for antineoplastic drugs.
引用
收藏
页码:1062 / 1066
页数:5
相关论文
共 30 条
  • [21] Pseudogene PLGLA exerts anti-tumor effects on hepatocellular carcinoma through modulating miR-324-3p/GLYATL1 axis
    Bao, Le
    Li, Pengfei
    Zhao, Hongying
    Chen, Long
    Wang, Youbin
    Liang, Shuang
    Liu, Jian
    DIGESTIVE AND LIVER DISEASE, 2022, 54 (07) : 918 - 926
  • [22] Dickkopf-1 inhibitor enhances the anti-tumor effects of sorafenib through inhibition of PI3K/Akt/Wnt signaling in hepatocellular carcinoma
    Seo, Sang Hyun
    Cho, Kyung Joo
    Park, Hye Jung
    Kim, Hye Mi
    Lee, Jae Seung
    Lee, Hye Won
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Seung Up
    JOURNAL OF HEPATOLOGY, 2023, 78 : S362 - S363
  • [23] Constituents of Compositae plants III. Anti-tumor promoting effects and cytotoxic activity against human cancer cell lines of triterpene diols and triols from edible chrysanthemum flowers
    Ukiya, M
    Akihisa, T
    Tokuda, H
    Suzuki, H
    Mukainaka, T
    Ichiishi, E
    Yasukawa, K
    Kasahara, Y
    Nishino, H
    CANCER LETTERS, 2002, 177 (01) : 7 - 12
  • [24] The anti-tumor effects of the recombinant toxin protein rLj-RGD3 from Lampetra japonica on pancreatic carcinoma Panc-1 cells in nude mice
    Wang, Yue
    Zheng, Yuanyuan
    Tu, Zuoyu
    Dai, Yongguo
    Xu, Hong
    Lv, Li
    Wang, Jihong
    PEPTIDES, 2017, 88 : 8 - 17
  • [25] Anti-Cancer Effects of YAP Inhibitor (CA3) in Combination with Sorafenib against Hepatocellular Carcinoma (HCC) in Patient-Derived Multicellular Tumor Spheroid Models (MCTS)
    Han, Sojung
    Lim, Ji Yeon
    Cho, Kyungjoo
    Lee, Hye Won
    Park, Jun Yong
    Ro, Simon Weonsang
    Kim, Kyung Sik
    Seo, Haeng Ran
    Kim, Do Young
    CANCERS, 2022, 14 (11)
  • [26] Nrf2-siRNA Enhanced the Anti-Tumor Effects of As2O3 in 5-Fluorouracil-Resistant Hepatocellular Carcinoma by Inhibiting HIF-1α/HSP70 Signaling
    Duan, Xuhua
    Xu, Wenze
    Li, Hao
    Wang, Manzhou
    Wang, Wenhui
    Lu, Huibin
    Zhang, Yancang
    Han, Xinwei
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2022, 9 : 1341 - 1352
  • [27] RETRACTED: Polydatin exerts anti-tumor effects against renal cell carcinoma cells via induction of caspase-dependent apoptosis and inhibition of the PI3K/Akt pathway (Retracted Article)
    Jin, Yi-Li
    Xin, Li-Min
    Zhou, Chang-Chun
    Ren, Yu
    ONCOTARGETS AND THERAPY, 2018, 11 : 8185 - 8195
  • [28] Novel sorafenib derivatives (SC-40, SC-43 and SC-60) show better anti-tumor effects than sorafenib in hepatocellular carcinoma through SHP-1/STAT3-mediated signaling pathway
    Tai, Wei-Tien
    Shiau, Chung-Wai
    Cheng, Ann-Lii
    Chen, Pel-Jer
    Chen, Kuen-Feng
    CANCER RESEARCH, 2012, 72
  • [29] RETRACTION: Polydatin exerts anti-tumor effects against renal cell carcinoma cells via induction of caspase-dependent apoptosis and inhibition of the PI3K/Akt pathway (Retraction of Vol 11, Pg 8185, 2018)
    Jin, Y-L
    Xin, L-M
    Zhou, C-C
    Ren, Y.
    ONCOTARGETS AND THERAPY, 2019, 12 : 4321 - 4321
  • [30] Activated human NK cells isolated from liver allograft have vigorous anti-tumor activity without showing any toxicity against one-haplotype identical intact cells: A novel concept in preventing recurrence of hepatocellular carcinoma in living-related donor liver transplantation.
    Ishiyama, K
    Ohdan, H
    Mitsuta, H
    Asahara, T
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 428 - 428